T46.0X1
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
Clinical Classification Guidelines
Inclusion Terms
- Poisoning by cardiac-stimulant glycosides and drugs of similar action NOS
Medical Intelligence & Overview
Poisoning by cardiac-stimulant glycosides and similar drugs occurs when these medications are accidentally ingested or absorbed in an amount that causes harm. Such substances are typically used to treat heart conditions by strengthening heart contractions and regulating rhythm. However, an unintentional overdose or exposure can lead to serious health issues. Recognizing the causes, symptoms, and importance of proper management can help prevent complications associated with this type of poisoning.
Causes & Symptoms
Clinical Causes: Misuse or misunderstanding of medication dosing Accidental ingestion, especially in children or vulnerable adults Mix-up of medicines with similar packaging or appearance Taking an overdose during self-medication without medical supervision Discontinued or expired medications being re-used without proper guidance
Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Confusion or dizziness Irregular heartbeat or palpitations Visual disturbances, such as blurred or yellow vision Weakness or fatigue Respiratory distress in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves reviewing patient history and medication use, conducting physical examinations, and performing laboratory tests. Blood tests may measure the levels of glycosides in the system to confirm poisoning. Electrocardiograms (ECGs) are essential for detecting abnormal heart rhythms related to toxicity. Additional assessments may include kidney and liver function tests to evaluate organ involvement and overall health status.
Treatment Protocols: Managing poisoning by cardiac-stimulant glycosides generally requires prompt medical intervention. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is T46.0X1 a billable ICD-10 code?
Yes, T46.0X1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.0X1?
Clinical documentation must specify the nature of Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference